pravastatin has been researched along with Albuminuria in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 8 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cadnapaphornchai, MA; George, DM; Gitomer, B; McFann, K; Schrier, RW; Strain, JD; Wang, W | 1 |
| Cadnapaphornchai, MA; George, DM; Masoumi, A; McFann, K; Schrier, RW; Strain, JD | 1 |
| Asselbergs, FW; Brouwers, FP; de Boer, RA; Gansevoort, RT; Hillege, HL; van Gilst, WH; van Veldhuisen, DJ | 1 |
| Arai, H; Minami, M; Murayama, T; Tamura, Y; Yokode, M | 1 |
| D'Haese, P; Geryl, H; Verhulst, A | 1 |
| Inoguchi, T; Kimura, S; Maeda, Y; Sonoda, N; Takayanagi, R; Yokomizo, H | 1 |
| Gad, HI | 1 |
| Cannon, CP; Gibson, CM; Murphy, SA; Nazer, B; Ray, KK | 1 |
| Asselbergs, FW; de Jong, PE; de Zeeuw, D; Diercks, GF; Hillege, HL; Janssen, WM; van Boven, AJ; van Gilst, WH; van Veldhuisen, DJ; Voors, AA | 1 |
| Asselbergs, FW; de Jong, PE; Gans, RO; Hillege, HL; Smit, AJ; van Gilst, WH; van Roon, AM | 1 |
| Asselbergs, FW; Bakker, SJ; de Jong, PE; Geluk, CA; Hillege, HL; van Gilst, WH; Zijlstra, F | 1 |
| Asselbergs, FW; Atthobari, J; Boersma, C; de Jong, PE; de Jong-van den Berg, LT; de Vries, R; Gansevoort, RT; Hillege, HL; Postma, MJ; van Gilst, WH | 1 |
| Asselbergs, FW; de Jong, PE; Gans, ROB; Hillege, HL; Smit, AJ; van der Harst, P; van Gilst, WH; van Roon, AM | 1 |
| Fujita, H; Ito, S; Kakei, M; Koshimura, J; Miura, T; Morii, T; Narita, T; Sasaki, H; Sato, T; Yamada, Y | 1 |
| De Leeuw, I; Van Gaal, L; Vertommen, J; Zhang, A | 1 |
| Bak, AA; Crijns, HJ; de Jong, PE; Diercks, GF; Janssen, WM; van Boven, AJ; van Gilst, WH | 1 |
| Mori, M; Nagai, T; Nakajima, K; Tomizawa, T | 1 |
| Kawagishi, T; Morii, H; Nishizawa, Y; Okuno, Y; Shoji, T; Toyokawa, A | 1 |
12 trial(s) available for pravastatin and Albuminuria
| Article | Year |
|---|---|
Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease.
Topics: Adolescent; Albuminuria; Child; Creatinine; Double-Blind Method; Heart Ventricles; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Magnetic Resonance Imaging; Organ Size; Polycystic Kidney, Autosomal Dominant; Pravastatin; Young Adult | 2014 |
Effect of statin therapy on disease progression in pediatric ADPKD: design and baseline characteristics of participants.
Topics: Adolescent; Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypertension; Hypertrophy, Left Ventricular; Kidney; Lisinopril; Male; Polycystic Kidney, Autosomal Dominant; Pravastatin; Renin-Angiotensin System; Young Adult | 2011 |
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Cardiovascular Diseases; Female; Follow-Up Studies; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin | 2011 |
No evidence for statin-induced proteinuria in healthy volunteers as assessed by proteomic analysis.
Topics: Adult; Aged; Albuminuria; Cross-Over Studies; Double-Blind Method; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pravastatin; Proteinuria; Proteome; Proteomics; Pyrimidines; Retinol-Binding Proteins; Rosuvastatin Calcium; Sulfonamides; Two-Dimensional Difference Gel Electrophoresis | 2011 |
Randomized comparison of pitavastatin and pravastatin treatment on the reduction of urinary albumin in patients with type 2 diabetic nephropathy.
Topics: Aged; Albuminuria; Biomarkers; Creatinine; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Male; Pravastatin; Quinolines; Treatment Outcome | 2012 |
Urinary albumin concentration and long-term cardiovascular risk in acute coronary syndrome patients: a PROVE IT-TIMI 22 substudy.
Topics: Acute Coronary Syndrome; Aged; Albuminuria; Anticholesteremic Agents; Atorvastatin; Female; Heart Failure; Heptanoic Acids; Humans; Male; Middle Aged; Models, Biological; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors | 2013 |
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cohort Studies; Double-Blind Method; Female; Follow-Up Studies; Fosinopril; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Life Tables; Male; Middle Aged; Pravastatin; Treatment Outcome | 2004 |
Effects of fosinopril and pravastatin on carotid intima-media thickness in subjects with increased albuminuria.
Topics: Albuminuria; Carotid Artery, Common; Double-Blind Method; Female; Fosinopril; Humans; Male; Middle Aged; Pravastatin; Predictive Value of Tests; Stroke; Tunica Intima; Tunica Media | 2005 |
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial.
Topics: Albuminuria; Antihypertensive Agents; Cardiovascular Diseases; Coronary Disease; Double-Blind Method; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Metabolic Syndrome; Middle Aged; Pravastatin; Survival Analysis | 2005 |
Long-term effects of pravastatin and fosinopril on peripheral endothelial function in albuminuric subjects.
Topics: Adult; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Brachial Artery; Double-Blind Method; Endothelium, Vascular; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Longitudinal Studies; Male; Middle Aged; Pravastatin; Vasodilation | 2008 |
Effects of pravastatin on lipid levels, in vitro oxidizability of non-HDL lipoproteins and microalbuminuria in IDDM patients.
Topics: Adult; Alanine Transaminase; Albuminuria; Aspartate Aminotransferases; Creatine Kinase; Cross-Over Studies; Diabetes Mellitus, Type 1; Enzyme Inhibitors; Evaluation Studies as Topic; Female; gamma-Glutamyltransferase; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lipoproteins; Male; Middle Aged; Oxidation-Reduction; Pravastatin | 1995 |
Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the Prevention of REnal and Vascular E
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cardiovascular Diseases; Double-Blind Method; Drug Therapy, Combination; Female; Fosinopril; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney Diseases; Male; Middle Aged; Pravastatin; Randomized Controlled Trials as Topic; Research Design | 2000 |
6 other study(ies) available for pravastatin and Albuminuria
| Article | Year |
|---|---|
Differential effect of statins on diabetic nephropathy in db/db mice.
Topics: Adiposity; Albuminuria; Animals; Blood Pressure; Body Weight; Creatinine; Diabetic Nephropathies; Fluorobenzenes; Insulin Resistance; Male; Mice; Oxidative Stress; Pravastatin; Pyrimidines; Quinolines; Real-Time Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides | 2011 |
Effects of pravastatin or 12/15 lipoxygenase pathway inhibitors on indices of diabetic nephropathy in an experimental model of diabetic renal disease.
Topics: Albuminuria; Animals; Anticholesteremic Agents; Arachidonate 12-Lipoxygenase; Arachidonate 15-Lipoxygenase; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypoglycemic Agents; Insulin; Kidney; Male; Oxidative Stress; Pravastatin; Rats; Rats, Wistar; Signal Transduction; Treatment Outcome | 2012 |
Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal
Topics: Adult; Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Cardiovascular Diseases; Cost-Benefit Analysis; Female; Fosinopril; Health Care Costs; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Male; Mass Screening; Middle Aged; Netherlands; Pravastatin; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic | 2006 |
Effects of long-term pravastatin treatment on serum and urinary monocyte chemoattractant protein-1 levels and renal function in type 2 diabetic patients with normoalbuminuria.
Topics: Aged; Albuminuria; Chemokine CCL2; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Middle Aged; Pravastatin | 2007 |
Effect of bezafibrate or pravastatin on serum lipid levels and albuminuria in NIDDM patients.
Topics: Albuminuria; Apolipoprotein A-I; Apolipoprotein B-100; Apolipoproteins B; Bezafibrate; Blood Pressure; Case-Control Studies; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Hypercholesterolemia; Hypolipidemic Agents; Insulin; Lipids; Male; Middle Aged; Pravastatin | 2000 |
Decreased albuminuria by pravastatin in hyperlipidemic diabetics.
Topics: Aged; Albuminuria; Diabetic Nephropathies; Female; Humans; Hyperlipidemias; Male; Middle Aged; Pravastatin | 1991 |